Literature DB >> 2285885

Tricyclic antidepressants inhibit voltage-dependent calcium channels and Na(+)-Ca2+ exchange in rat brain cortex synaptosomes.

P A Lavoie1, G Beauchamp, R Elie.   

Abstract

We have used a resting (5 mM K+) or depolarizing (60 mM K+) choline-based medium, and a nondepolarizing sodium-based or choline-based medium, to characterize the inhibitory potential of tricyclic antidepressants against the voltage-dependent calcium channels or the Na(+)-Ca2+ exchange process, respectively, in synaptosomes from rat brain cortex. Imipramine, desipramine, amitriptyline, and clomipramine inhibited net K(+)-induced 45Ca uptake with similar IC50 values (26-31 microM), and this uptake was also inhibited by diltiazem with an IC50 of 36 microM; these results indicate an inhibition of voltage-dependent calcium channels by tricyclic antidepressants. The net uptake of 45Ca induced by Na(+)-Ca2+ exchange was also inhibited by the four tricyclic antidepressants tested, but not by diltiazem; imipramine (IC50 = 94 microM) was a more potent inhibitor of this process than desipramine (IC50 = 151 microM), and the IC50 values of amitriptyline (107 microM) and clomipramine (97 microM) were similar to that of imipramine. Some degree (approximately 25%) of brain calcium channel blockade could be present at the steady-state concentrations of tricyclic antidepressants expected to occur therapeutic use of these compounds to treat depression or panic disorder.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2285885     DOI: 10.1139/y90-215

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  12 in total

1.  Effects of chronic lithium, amitriptyline, and electroconvulsive shock, on calcium channel binding in a rat brain homogenate.

Authors:  P H Silverstone; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 2.  The pharmacotherapy of chronic pain: a review.

Authors:  Mary E Lynch; C Peter N Watson
Journal:  Pain Res Manag       Date:  2006       Impact factor: 3.037

Review 3.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  Absence of stereoselectivity of some tricyclic antidepressants for the inhibition of depolarization-induced calcium uptake in rat cingulate cortex synaptosomes.

Authors:  P A Lavoie; G Beauchamp; R Elie
Journal:  J Psychiatry Neurosci       Date:  1994-05       Impact factor: 6.186

5.  Effect of some stereoisomeric tricyclic antidepressants on 45Ca uptake in synaptosomes from rat hippocampus.

Authors:  G Beauchamp; P A Lavoie; R Elie
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 6.  Antidepressants for the treatment of chronic pain.

Authors:  Bénédicte Verdu; Isabelle Decosterd; Thierry Buclin; Friedrich Stiefel; Alexandre Berney
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 7.  An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy.

Authors:  Che S Zin; Lisa M Nissen; Maree T Smith; James P O'Callaghan; Brendan J Moore
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 8.  Depression and antidepressants: molecular and cellular aspects.

Authors:  Cristina Lanni; Stefano Govoni; Adele Lucchelli; Cinzia Boselli
Journal:  Cell Mol Life Sci       Date:  2009-06-12       Impact factor: 9.261

9.  Milnacipran inhibits glutamatergic N-methyl-D-aspartate receptor activity in spinal dorsal horn neurons.

Authors:  Tatsuro Kohno; Masafumi Kimura; Mika Sasaki; Hideaki Obata; Fumimasa Amaya; Shigeru Saito
Journal:  Mol Pain       Date:  2012-06-19       Impact factor: 3.395

10.  Dual action of amitriptyline on NMDA receptors: enhancement of Ca-dependent desensitization and trapping channel block.

Authors:  Yulia D Stepanenko; Sergei I Boikov; Dmitry A Sibarov; Polina A Abushik; Nina P Vanchakova; Daria Belinskaia; Natalia N Shestakova; Sergei M Antonov
Journal:  Sci Rep       Date:  2019-12-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.